Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39051

DNAH5 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

This CRISPR/Cas9-edited polyclonal knockout cell population features targeted disruption of the DNAH5 gene in Raji B lymphocytes. DNAH5 encodes an axonemal dynein heavy chain essential for ciliary motility, regulated by transcription factors such as FOXJ1 and RFX2. Loss of DNAH5 disrupts outer dynein arm complex assembly and interactions with factors like DNAI1 and DNAI2. Designed for primary ciliary dyskinesia research, this knockout model enables antibody validation, protein interaction studies, and pathway analysis in a tractable immune cell background. Key applications include co-immunoprecipitation, western blotting, and mass spectrometry-based assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    DNAH5

    Gene Identifier

    NCBI Gene ID 1767

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

This product consists of a CRISPR/Cas9-edited polyclonal knockout cell population in which the DNAH5 gene has been disrupted within Raji cells through genome-wide gene disruption methods. The polyclonal format provides a heterogeneous pool of edited cells, each carrying distinct genomic modifications at the targeted locus, enabling robust loss-of-function studies without clonal isolation. By disrupting the endogenous DNAH5 locus, researchers can model the absence of functional axonemal dynein heavy chain 5, a component essential for outer dynein arm assembly and ciliary motility, in a human B lymphocyte background. This gene-edited population is produced via CRISPR/Cas9-mediated gene targeting and is supplied as a ready-to-use polyclonal pool suitable for immediate downstream applications, including protein expression analysis, interaction studies, and functional screening.

The Raji host cell line is an Epstein-Barr virus (EBV)-positive B lymphocyte cell line originally derived from a Burkitt lymphoma patient. As a suspension-adapted lymphoid cell model, Raji cells retain critical features of antigen-presenting cells and are widely used in immunology, virology, and cancer biology. They endogenously express key components of the major histocompatibility complex (MHC) class I and class II pathways, supporting their role in antigen presentation and T cell activation studies. The EBV-transformed nature of these cells also provides a tractable system for studying viral latency and lymphomagenesis. Importantly, Raji cells do not normally express motile cilia, so DNAH5 knockout in this context creates a unique platform for investigating ciliary protein functions outside of the ciliated cell environment, including potential non-ciliary roles and protein interaction networks.

DNAH5 encodes a heavy chain subunit of the outer dynein arm, a large motor protein complex that powers ciliary and flagellar beating. The DNAH5 protein interacts directly with other dynein components such as DNAI1, DNAI2, and DNAL1 to assemble a functional outer dynein arm along the axonemal microtubules. Its expression and assembly are transcriptionally regulated by upstream factors including FOXJ1, RFX2, and RFX3, which are master regulators of ciliogenesis and motile cilia differentiation. Notch signaling also modulates ciliogenesis pathways that ultimately converge on genes like DNAH5. Downstream, functional DNAH5 is required for proper ciliary beat frequency and efficient mucociliary clearance, processes that depend on the coordinated movement of multiple dynein arm components. In the Raji knockout model, disruption of DNAH5 protein expression abolishes its interactions with DNAI1 and other outer dynein arm partners, making it an effective tool for dissecting assembly pathways and protein?Cprotein interactions outside the context of intact cilia.

Despite the Raji cell line??s lack of motile cilia, the DNAH5 knockout model holds significant value for studying primary ciliary dyskinesia (PCD) and related syndromes. Because many ciliary proteins, including DNAH5, have expression patterns and interacting partners that extend beyond ciliated tissues, this B lymphocyte model allows investigation of DNAH5??s biochemical properties, post-translational modifications, and binding interactions in a well-characterized, easily manipulated host. The model can be used to validate antibodies raised against DNAH5 or other outer dynein arm proteins, ensuring specificity in a null background. Moreover, the Raji system supports high-throughput screening for small molecules or genetic modifiers that may influence DNAH5 expression or stability, a context particularly relevant for disorders like Kartagener syndrome and chronic respiratory infections where DNAH5 mutations are causative.

Researchers can employ this polyclonal knockout population in a variety of experimental workflows, from co-immunoprecipitation and mass spectrometry-based interactomics to immunofluorescence validation of commercial antibodies. Western blotting using lysates from these cells serves as a clear negative control for detecting DNAH5 protein expression, while flow cytometry permits rapid assessment of any surface markers potentially affected by DNAH5-related pathways. The combination of a knockout B lymphocyte host and DNAH5 disruption is especially suited for studying humoral immune function and antigen presentation when ciliary protein expression may play an underappreciated role. Additional applications include probing the influence of upstream regulators like FOXJ1 or RFX2 on DNAH5 downstream targets, and comparative proteomics to identify novel binding partners. For further details or custom requests, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)